-
Share
20,826 Posts.
873
07/08/19
09:38
Share
imo
Name me any listed small biotech that requires more than its current market cap for its 2 drugs at either phase 1 or phase 2 etc
Cantrixil phase 1 in progress
GDC0084 phase 11a - 11b
imo
This has nothing to do with being astute and all to do with capital and dilution
imo
The market is forward thinking and knows what lays ahead etc
-